Cargando...
Sarcoidosis extent relates to molecular variability
The molecular basis of sarcoidosis phenotype heterogeneity and its relationship to effective treatment of sarcoidosis have not been elucidated. Peripheral samples from sarcoidosis subjects who participated in a Phase II study of golimumab [anti‐tumour necrosis factor (TNF)‐α] and ustekinumab [anti‐i...
Guardado en:
| Publicado en: | Clin Exp Immunol |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5422855/ https://ncbi.nlm.nih.gov/pubmed/28205212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12942 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|